Literature DB >> 18563304

Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.

Janet K Brewer1.   

Abstract

This study investigates the causes of the observed linkage between depression and later onset of cancer. The prevailing view is that cancer in depressed patients results from a weakened immune system. However, molecular biologists have recognized that dysregulation of the ras proto-oncogene results in impaired serotonin and dopamine synthesis manifesting as major depression. A qualitative review of the literature showed that (1) studies using the Minnesota Multiphasic Personality Inventory showed a greater correlation between depression and later cancer onset than those employing other measures and (2) the more related the cancer type was to the Ras oncogene family, the greater the correlation between depression and later cancer onset. These results support the hypothesis that the ras proto-oncogene plays a role in the etiology of depression and could be the common denominator in long-observed depression/cancer linkages. Previous depression/cancer linkage studies are confounded in that they failed to analyze cancer type and accurately diagnose depression.

Entities:  

Mesh:

Year:  2008        PMID: 18563304     DOI: 10.1007/s12031-008-9078-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  90 in total

1.  ASPECTS OF PERSONALITY OF MEN WITH LUNG CANCER.

Authors:  D M KISSEN
Journal:  Acta Psychother Psychosom       Date:  1963

2.  Psychological influences on cancer and ischaemic heart disease.

Authors:  A J Pelosi; L Appleby
Journal:  BMJ       Date:  1992-05-16

3.  Chronically depressed mood and cancer risk in older persons.

Authors:  B W Penninx; J M Guralnik; M Pahor; L Ferrucci; J R Cerhan; R B Wallace; R J Havlik
Journal:  J Natl Cancer Inst       Date:  1998-12-16       Impact factor: 13.506

Review 4.  Psycho-oncology and cancer: psychoneuroimmunology and cancer.

Authors:  J K Kiecolt-Glaser; T F Robles; K L Heffner; T J Loving; R Glaser
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

Review 5.  Chronic mood disorder and depressive personality.

Authors:  M T Shea; R M Hirschfeld
Journal:  Psychiatr Clin North Am       Date:  1996-03

6.  Regulation of tetradecanoyl phorbol acetate-induced responses in NIH 3T3 cells by GAP, the GTPase-activating protein associated with p21c-ras.

Authors:  M Nori; G L'Allemain; M J Weber
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

7.  Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.

Authors:  J J Oudejans; R J Slebos; F A Zoetmulder; W J Mooi; S Rodenhuis
Journal:  Int J Cancer       Date:  1991-12-02       Impact factor: 7.396

8.  Activation of Ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation.

Authors:  A Porras; A R Nebreda; M Benito; E Santos
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

9.  Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.

Authors:  D A Spandidos
Journal:  Anticancer Res       Date:  1987 Sep-Oct       Impact factor: 2.480

10.  Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture.

Authors:  W B Malarkey; M Kennedy; L E Allred; G Milo
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

View more
  6 in total

1.  Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample.

Authors:  Alden L Gross; Joseph J Gallo; William W Eaton
Journal:  Cancer Causes Control       Date:  2009-11-03       Impact factor: 2.506

Review 2.  Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.

Authors:  Muin J Khoury; Steven B Clauser; Andrew N Freedman; Elizabeth M Gillanders; Russ E Glasgow; William M P Klein; Sheri D Schully
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-27       Impact factor: 4.254

Review 3.  The emerging role of large immunophilin FK506 binding protein 51 in cancer.

Authors:  S Romano; A Sorrentino; A L Di Pace; G Nappo; C Mercogliano; M F Romano
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 4.  Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine.

Authors:  Oscar Fraile-Martinez; Miguel A Alvarez-Mon; Cielo Garcia-Montero; Leonel Pekarek; Luis G Guijarro; Guillermo Lahera; Miguel A Saez; Jorge Monserrat; Domitila Motogo; Javier Quintero; Melchor Alvarez-Mon; Miguel A Ortega
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

5.  Mood disorders and risk of lung cancer in the EAGLE case-control study and in the U.S. Veterans Affairs inpatient cohort.

Authors:  David E Capo-Ramos; Ying Gao; Jay H Lubin; David P Check; Lynn R Goldin; Angela C Pesatori; Dario Consonni; Pier Alberto Bertazzi; Andrew J Saxon; Andrew W Bergen; Neil E Caporaso; Maria Teresa Landi
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

6.  Advanced Glycation End Products Increase MDM2 Expression via Transcription Factor KLF5.

Authors:  Pu Wang; Yu Cheng Lu; Yuan Fei Li; Lan Wang; Shao Chin Lee
Journal:  J Diabetes Res       Date:  2018-09-09       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.